RegulatoryMay 12, 2026, 04:23 PM
Burzynski Research Institute Expects SEC Reporting Delinquency
AI Summary
Burzynski Research Institute announced that its primary funder, Dr. Stanislaw R. Burzynski, will no longer cover SEC reporting costs due to limited resources. As a result, the company expects to become delinquent in its reporting obligations, including the upcoming Annual Report on Form 10-K for the fiscal year ended February 28, 2026. This non-compliance could lead to severe consequences from the SEC, such as temporary trading suspensions or the revocation of the company's securities registration, significantly impairing trading liquidity.
Key Highlights
- Burzynski Research Institute historically funded operations through payments from Dr. Stanislaw R. Burzynski.
- Dr. Burzynski, the company's President, CFO, and Chairman, will no longer fund SEC reporting costs due to limited resources.
- The company expects to be unable to timely file its Annual Report on Form 10-K for the fiscal year ended February 28, 2026.
- Failure to file will result in delinquency under the Exchange Act, potentially leading to SEC actions.
- Potential SEC actions include temporary trading suspension under Section 12(k) or administrative proceedings to suspend/revoke registration under Section 12(j).
- Such actions could severely reduce or eliminate trading liquidity for the company's securities.